Peringatan Keamanan

Since glycylcyclines are similar to tetracyclines, they share many of the same side effects and contraindications as tetracyclines. These side effects may include nausea/vomiting, headache, photosensitivity, discoloration of growing teeth, and fetal damage.

Tigecycline

DB00560

small molecule approved

Deskripsi

Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. It was granted fast-track approval by the U.S. Food and Drug Administration (FDA) on June 17, 2005.

Struktur Molekul 2D

Berat 585.6487
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 27-43 hours
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Tigecycline is not extensively metabolized. In vitro studies with tigecycline using human liver microsomes, liver slices, and hepatocytes led to the formation of only trace amounts of metabolites. A glucuronide, an N-acetyl metabolite, and a tigecycline epimer (each at no more than 10% of the administered dose) are the primary metabolites.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

285 Data
Succinylcholine The therapeutic efficacy of Succinylcholine can be increased when used in combination with Tigecycline.
Metocurine iodide The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Tigecycline.
Gallamine triethiodide The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Tigecycline.
Cisatracurium Tigecycline may increase the neuromuscular blocking activities of Cisatracurium.
Rocuronium The therapeutic efficacy of Rocuronium can be increased when used in combination with Tigecycline.
Atracurium besylate The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Tigecycline.
Doxacurium The therapeutic efficacy of Doxacurium can be increased when used in combination with Tigecycline.
Mivacurium The therapeutic efficacy of Mivacurium can be increased when used in combination with Tigecycline.
Decamethonium The therapeutic efficacy of Decamethonium can be increased when used in combination with Tigecycline.
Metocurine The therapeutic efficacy of Metocurine can be increased when used in combination with Tigecycline.
Pancuronium The therapeutic efficacy of Pancuronium can be increased when used in combination with Tigecycline.
Pipecuronium The therapeutic efficacy of Pipecuronium can be increased when used in combination with Tigecycline.
Vecuronium The therapeutic efficacy of Vecuronium can be increased when used in combination with Tigecycline.
Rapacuronium The therapeutic efficacy of Rapacuronium can be increased when used in combination with Tigecycline.
Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Tigecycline.
Neosaxitoxin The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Tigecycline.
Atracurium The therapeutic efficacy of Atracurium can be increased when used in combination with Tigecycline.
Gallamine The therapeutic efficacy of Gallamine can be increased when used in combination with Tigecycline.
Alcuronium The therapeutic efficacy of Alcuronium can be increased when used in combination with Tigecycline.
Tubocurarine The therapeutic efficacy of Tubocurarine can be increased when used in combination with Tigecycline.
Mecamylamine Tigecycline may increase the neuromuscular blocking activities of Mecamylamine.
Mipomersen Tigecycline may increase the hepatotoxic activities of Mipomersen.
Flucloxacillin The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Tigecycline.
Piperacillin The therapeutic efficacy of Piperacillin can be decreased when used in combination with Tigecycline.
Ampicillin The therapeutic efficacy of Ampicillin can be decreased when used in combination with Tigecycline.
Phenoxymethylpenicillin The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Tigecycline.
Dicloxacillin The therapeutic efficacy of Dicloxacillin can be decreased when used in combination with Tigecycline.
Carbenicillin The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Tigecycline.
Nafcillin The therapeutic efficacy of Nafcillin can be decreased when used in combination with Tigecycline.
Oxacillin The therapeutic efficacy of Oxacillin can be decreased when used in combination with Tigecycline.
Hetacillin The therapeutic efficacy of Hetacillin can be decreased when used in combination with Tigecycline.
Benzylpenicilloyl polylysine The therapeutic efficacy of Benzylpenicilloyl polylysine can be decreased when used in combination with Tigecycline.
Mezlocillin The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Tigecycline.
Cyclacillin The therapeutic efficacy of Cyclacillin can be decreased when used in combination with Tigecycline.
Benzylpenicillin The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Tigecycline.
Amoxicillin The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Tigecycline.
Azlocillin The therapeutic efficacy of Azlocillin can be decreased when used in combination with Tigecycline.
Cloxacillin The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Tigecycline.
Amdinocillin The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Tigecycline.
Bacampicillin The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Tigecycline.
Meticillin The therapeutic efficacy of Meticillin can be decreased when used in combination with Tigecycline.
Pivampicillin The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Tigecycline.
Pivmecillinam The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with Tigecycline.
Ticarcillin The therapeutic efficacy of Ticarcillin can be decreased when used in combination with Tigecycline.
Azidocillin The therapeutic efficacy of Azidocillin can be decreased when used in combination with Tigecycline.
Carindacillin The therapeutic efficacy of Carindacillin can be decreased when used in combination with Tigecycline.
Procaine benzylpenicillin The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Tigecycline.
Sultamicillin The therapeutic efficacy of Sultamicillin can be decreased when used in combination with Tigecycline.
Temocillin The therapeutic efficacy of Temocillin can be decreased when used in combination with Tigecycline.
Epicillin The therapeutic efficacy of Epicillin can be decreased when used in combination with Tigecycline.
Pheneticillin The therapeutic efficacy of Pheneticillin can be decreased when used in combination with Tigecycline.
Carfecillin The therapeutic efficacy of Carfecillin can be decreased when used in combination with Tigecycline.
Propicillin The therapeutic efficacy of Propicillin can be decreased when used in combination with Tigecycline.
Clometocillin The therapeutic efficacy of Clometocillin can be decreased when used in combination with Tigecycline.
Sulbenicillin The therapeutic efficacy of Sulbenicillin can be decreased when used in combination with Tigecycline.
Penamecillin The therapeutic efficacy of Penamecillin can be decreased when used in combination with Tigecycline.
Talampicillin The therapeutic efficacy of Talampicillin can be decreased when used in combination with Tigecycline.
Aspoxicillin The therapeutic efficacy of Aspoxicillin can be decreased when used in combination with Tigecycline.
Metampicillin The therapeutic efficacy of Metampicillin can be decreased when used in combination with Tigecycline.
Warfarin The serum concentration of Warfarin can be increased when it is combined with Tigecycline.
Acenocoumarol The serum concentration of Acenocoumarol can be increased when it is combined with Tigecycline.
(R)-warfarin The serum concentration of (R)-warfarin can be increased when it is combined with Tigecycline.
R,S-Warfarin alcohol The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Tigecycline.
S,R-Warfarin alcohol The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Tigecycline.
(S)-Warfarin The serum concentration of (S)-Warfarin can be increased when it is combined with Tigecycline.
Bismuth subcitrate potassium The serum concentration of Tigecycline can be decreased when it is combined with Bismuth subcitrate potassium.
Zinc Zinc can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc trihydroxide Zinc trihydroxide can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc Substituted Heme C Zinc Substituted Heme C can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Polaprezinc Polaprezinc can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc oxide Zinc oxide can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc sulfate Zinc sulfate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc citrate Zinc citrate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc picolinate Zinc picolinate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc gluconate Zinc gluconate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acetylcysteine zinc Acetylcysteine zinc can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc ascorbate Zinc ascorbate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc acetate Zinc acetate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc glycinate Zinc glycinate can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc chloride Zinc chloride can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc sulfate, unspecified form Zinc sulfate, unspecified form can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc cation Zinc cation can cause a decrease in the absorption of Tigecycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
BCG vaccine The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Tigecycline.
Typhoid vaccine The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Tigecycline.
Etonogestrel The serum concentration of Etonogestrel can be decreased when it is combined with Tigecycline.
Desogestrel The serum concentration of Desogestrel can be decreased when it is combined with Tigecycline.
Megestrol acetate The serum concentration of Megestrol acetate can be decreased when it is combined with Tigecycline.
Levonorgestrel The serum concentration of Levonorgestrel can be decreased when it is combined with Tigecycline.
Dydrogesterone The serum concentration of Dydrogesterone can be decreased when it is combined with Tigecycline.
Progesterone The serum concentration of Progesterone can be decreased when it is combined with Tigecycline.
Medroxyprogesterone acetate The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Tigecycline.
Norethisterone The serum concentration of Norethisterone can be decreased when it is combined with Tigecycline.
Ethynodiol diacetate The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Tigecycline.
Norgestimate The serum concentration of Norgestimate can be decreased when it is combined with Tigecycline.
Drospirenone The serum concentration of Drospirenone can be decreased when it is combined with Tigecycline.
Allylestrenol The serum concentration of Allylestrenol can be decreased when it is combined with Tigecycline.
Cyproterone acetate The serum concentration of Cyproterone acetate can be decreased when it is combined with Tigecycline.
Norelgestromin The serum concentration of Norelgestromin can be decreased when it is combined with Tigecycline.
Gestodene The serum concentration of Gestodene can be decreased when it is combined with Tigecycline.
Hydroxyprogesterone caproate The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Tigecycline.

Target Protein

16S ribosomal RNA
30S ribosomal protein S9 rpsI
30S ribosomal protein S12 rpsL
30S ribosomal protein S13 rpsM
30S ribosomal protein S14 rpsN
30S ribosomal protein S19 rpsS

Referensi & Sumber

Synthesis reference: Mahdi Fawzi, Tianmin Zhu, Syed Shah, "Tigecycline compositons and methods of preparation." U.S. Patent US20060247181, issued November 02, 2006.
Artikel (PubMed)
  • PMID: 16863487
    Rose WE, Rybak MJ: Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy. 2006 Aug;26(8):1099-110.
  • PMID: 16790575
    Kasbekar N: Tigecycline: a new glycylcycline antimicrobial agent. Am J Health Syst Pharm. 2006 Jul 1;63(13):1235-43.

Contoh Produk & Brand

Produk: 16 • International brands: 0
Produk
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/10mL • Intravenous • US • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/5mL • Intravenous • US • Generic • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/5mL • Intravenous • US • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/1 • Intravenous • US • Generic • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/5mL • Intravenous • US • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/10mL • Intravenous; Parenteral • US • Generic • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/1 • Intravenous • US • Generic • Approved
  • Tigecycline
    Injection, powder, lyophilized, for solution • 50 mg/5mL • Intravenous • US • Generic • Approved
Menampilkan 8 dari 16 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul